Castleman Disease Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: C6DFF680CB3BEN
Market Monitor Global

Abstracts

Castleman disease is a rare condition of lymph nodes and similar tissues. This condition occurs when too many non-cancer cells started to grow in the lymph node. After initial growth hard growth started to form. Usually, it occurs in the chest, abdomen or neck. This condition is also called as angiofollicular lymph node hyperplasia. There are no known risk factors for castleman disease, but it usually occur in adults with weakened immune system.

This report contains market size and forecasts of Castleman Disease Treatment in Global, including the following market information:

Global Castleman Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Castleman Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Castleman Disease Treatment include Johnson & Johnson, F.Hoffmann-La Roche, Bristol-Myers Squibb, Merck, Pfizer, Hospira, Incyte and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Castleman Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Castleman Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Castleman Disease Treatment Market Segment Percentages, by Type, 2021 (%)

• Monoclonal Antibodies
• Chemotherapy
• Radiation Therapy
• Immunotherapy
• Corticosteroids
• Antiviral Drugs

Global Castleman Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Castleman Disease Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinical
• Ambulatory Care Units

Global Castleman Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Castleman Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Castleman Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Castleman Disease Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson & Johnson
• F.Hoffmann-La Roche
• Bristol-Myers Squibb
• Merck
• Pfizer
• Hospira
• Incyte
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Castleman Disease Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Castleman Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CASTLEMAN DISEASE TREATMENT OVERALL MARKET SIZE

2.1 Global Castleman Disease Treatment Market Size: 2021 VS 2028
2.2 Global Castleman Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Castleman Disease Treatment Players in Global Market
3.2 Top Global Castleman Disease Treatment Companies Ranked by Revenue
3.3 Global Castleman Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Castleman Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Castleman Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Castleman Disease Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Castleman Disease Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Castleman Disease Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Castleman Disease Treatment Market Size Markets, 2021 & 2028
  4.1.2 Monoclonal Antibodies
  4.1.3 Chemotherapy
  4.1.4 Radiation Therapy
  4.1.5 Immunotherapy
  4.1.6 Corticosteroids
  4.1.7 Antiviral Drugs
4.2 By Type - Global Castleman Disease Treatment Revenue & Forecasts
  4.2.1 By Type - Global Castleman Disease Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Castleman Disease Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Castleman Disease Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Castleman Disease Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinical
  5.1.4 Ambulatory Care Units
5.2 By Application - Global Castleman Disease Treatment Revenue & Forecasts
  5.2.1 By Application - Global Castleman Disease Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Castleman Disease Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Castleman Disease Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Castleman Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Castleman Disease Treatment Revenue & Forecasts
  6.2.1 By Region - Global Castleman Disease Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Castleman Disease Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Castleman Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Castleman Disease Treatment Revenue, 2017-2028
  6.3.2 US Castleman Disease Treatment Market Size, 2017-2028
  6.3.3 Canada Castleman Disease Treatment Market Size, 2017-2028
  6.3.4 Mexico Castleman Disease Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Castleman Disease Treatment Revenue, 2017-2028
  6.4.2 Germany Castleman Disease Treatment Market Size, 2017-2028
  6.4.3 France Castleman Disease Treatment Market Size, 2017-2028
  6.4.4 U.K. Castleman Disease Treatment Market Size, 2017-2028
  6.4.5 Italy Castleman Disease Treatment Market Size, 2017-2028
  6.4.6 Russia Castleman Disease Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Castleman Disease Treatment Market Size, 2017-2028
  6.4.8 Benelux Castleman Disease Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Castleman Disease Treatment Revenue, 2017-2028
  6.5.2 China Castleman Disease Treatment Market Size, 2017-2028
  6.5.3 Japan Castleman Disease Treatment Market Size, 2017-2028
  6.5.4 South Korea Castleman Disease Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Castleman Disease Treatment Market Size, 2017-2028
  6.5.6 India Castleman Disease Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Castleman Disease Treatment Revenue, 2017-2028
  6.6.2 Brazil Castleman Disease Treatment Market Size, 2017-2028
  6.6.3 Argentina Castleman Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Castleman Disease Treatment Revenue, 2017-2028
  6.7.2 Turkey Castleman Disease Treatment Market Size, 2017-2028
  6.7.3 Israel Castleman Disease Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Castleman Disease Treatment Market Size, 2017-2028
  6.7.5 UAE Castleman Disease Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Corporate Summary
  7.1.2 Johnson & Johnson Business Overview
  7.1.3 Johnson & Johnson Castleman Disease Treatment Major Product Offerings
  7.1.4 Johnson & Johnson Castleman Disease Treatment Revenue in Global Market (2017-2022)
  7.1.5 Johnson & Johnson Key News
7.2 F.Hoffmann-La Roche
  7.2.1 F.Hoffmann-La Roche Corporate Summary
  7.2.2 F.Hoffmann-La Roche Business Overview
  7.2.3 F.Hoffmann-La Roche Castleman Disease Treatment Major Product Offerings
  7.2.4 F.Hoffmann-La Roche Castleman Disease Treatment Revenue in Global Market (2017-2022)
  7.2.5 F.Hoffmann-La Roche Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb Castleman Disease Treatment Major Product Offerings
  7.3.4 Bristol-Myers Squibb Castleman Disease Treatment Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Castleman Disease Treatment Major Product Offerings
  7.4.4 Merck Castleman Disease Treatment Revenue in Global Market (2017-2022)
  7.4.5 Merck Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Castleman Disease Treatment Major Product Offerings
  7.5.4 Pfizer Castleman Disease Treatment Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Hospira
  7.6.1 Hospira Corporate Summary
  7.6.2 Hospira Business Overview
  7.6.3 Hospira Castleman Disease Treatment Major Product Offerings
  7.6.4 Hospira Castleman Disease Treatment Revenue in Global Market (2017-2022)
  7.6.5 Hospira Key News
7.7 Incyte
  7.7.1 Incyte Corporate Summary
  7.7.2 Incyte Business Overview
  7.7.3 Incyte Castleman Disease Treatment Major Product Offerings
  7.7.4 Incyte Castleman Disease Treatment Revenue in Global Market (2017-2022)
  7.7.5 Incyte Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Castleman Disease Treatment Major Product Offerings
  7.8.4 Novartis Castleman Disease Treatment Revenue in Global Market (2017-2022)
  7.8.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Castleman Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Castleman Disease Treatment Market Drivers in Global Market
Table 3. Castleman Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Castleman Disease Treatment in Global Market
Table 5. Top Castleman Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Castleman Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Castleman Disease Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Castleman Disease Treatment Product Type
Table 9. List of Global Tier 1 Castleman Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Castleman Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Castleman Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Castleman Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Castleman Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Castleman Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Castleman Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Castleman Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Castleman Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Castleman Disease Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Castleman Disease Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Castleman Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Castleman Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Castleman Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Castleman Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Castleman Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Castleman Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Castleman Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Castleman Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Castleman Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Castleman Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Castleman Disease Treatment Product Offerings
Table 32. Johnson & Johnson Castleman Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 33. F.Hoffmann-La Roche Corporate Summary
Table 34. F.Hoffmann-La Roche Castleman Disease Treatment Product Offerings
Table 35. F.Hoffmann-La Roche Castleman Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Castleman Disease Treatment Product Offerings
Table 38. Bristol-Myers Squibb Castleman Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Castleman Disease Treatment Product Offerings
Table 41. Merck Castleman Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Castleman Disease Treatment Product Offerings
Table 44. Pfizer Castleman Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Hospira Corporate Summary
Table 46. Hospira Castleman Disease Treatment Product Offerings
Table 47. Hospira Castleman Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Incyte Corporate Summary
Table 49. Incyte Castleman Disease Treatment Product Offerings
Table 50. Incyte Castleman Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Castleman Disease Treatment Product Offerings
Table 53. Novartis Castleman Disease Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Castleman Disease Treatment Segment by Type in 2021
Figure 2. Castleman Disease Treatment Segment by Application in 2021
Figure 3. Global Castleman Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Castleman Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Castleman Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Castleman Disease Treatment Revenue in 2021
Figure 8. By Type - Global Castleman Disease Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Castleman Disease Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Castleman Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Castleman Disease Treatment Revenue Market Share, 2017-2028
Figure 12. US Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Castleman Disease Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Castleman Disease Treatment Revenue Market Share, 2017-2028
Figure 24. China Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Castleman Disease Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Castleman Disease Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Castleman Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Castleman Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F.Hoffmann-La Roche Castleman Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Castleman Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Castleman Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Castleman Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hospira Castleman Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Incyte Castleman Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Castleman Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)